All ISCRM activities adhere to the highest standards of ethics. Noted bioethicists are involved in every stage of research design, operations, and oversight. Formal training in bioethics occurs before study or research commences, and procedures are monitored thereafter to insure compliance. ISCRM follows all oversight and transparency protocols in accordance with University of Washington policies.

Oversight of the Team

Drs. Murry, Ruohola-Baker and Ware are internationally recognized researchers responsible for planning, oversight, and the scientific goals of ISCRM. They report to the office of the Dean of the School of Medicine, as well as to an internal oversight committee chaired by Dr. Charles Alpers, Chair of the UW Department of Pathology. In addition, ISCRM also receives advice and feedback on the direction of the Institute’s science from an external scientific advisory board that includes scientists who are considered leading experts in the field of regenerative medicine, and meets on an annual basis.

Oversight of Embryonic Stem Cell Research

The University of Washington established the Embryonic Stem Cell Research Oversight Committee (ESCRO), which exists to review and approve research involving human embryonic stem cells (hESC). The ESCRO Committee review ensures that both institutional and public concerns regarding sensitive ethical, legal, scientific, and policy issues unique to hESC research are addressed. For more information please visit the ESCRO website.

Scientific Advisory Board

Juan Carlos Izpisua Belmonte, PhD
Professor and Roger Guillemin Chair
Salk Institute for Biological Studies
Jane S. Lebkowski, PhD
President, Research & Development
Regenerative Patch Technologies
Sean J. Morrison, PhD
Investigator, Howard Hughes Medical Institute
Director, Children’s Research Institute, Mary McDermott Cook Chair in Pediatric Genetics, University of Texas Southwestern Medical Center
David Scadden, MD
Gerald and Darlene Jordan Professor of Medicine at Harvard University; Co-Director, Harvard Stem Cell Institute; Chair; Department of Stem Cell and Regenerative Biology, Harvard University; Director, Center for Regenerative Medicine, Massachusetts General Hospital
Magdalena Zernicka-Goetz, PhD
Professor of Mammalian Development and Stem Cell Biology
University of Cambridge, UK